Recent Updates
Recently added Catalysts
VNDA Neutral Sentiment

Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025

Key Takeaway: Vanda Pharmaceuticals Inc. has announced that it will release its financial results for the first quarter of 2025 on May 7, 2025, after market close. Following the release, the company will host a conference call at 4:30 PM ET to discuss the results and corporate activities. The event will also be accessible online for investors, allowing for both live participation and replay options.
Price reaction · baseline $4.44 (2025-05-01 close) · hit after-hours · 3 other VNDA headline(s) in the window, move may be shared
day 0 close · peak
+2.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Vanda Pharmaceuticals will announce first quarter results for 2025.
  • The conference call will provide insights into corporate activities.
  • The event will be broadcast live and archived for later access.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

Conference Call and Webcast to Follow
WASHINGTON, May 2, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2025 on Wednesday, May 7, 2025, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, May 7, 2025, during which management will discuss the first quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 9941754.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, May 7, 2025, beginning at 8:30 PM ET and will be accessible until Wednesday, May 14, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 9941754.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies

Frequently Asked Questions

When will Vanda Pharmaceuticals release Q1 2025 results?

Vanda Pharmaceuticals will release Q1 2025 results on May 7, 2025.

What time is Vanda's conference call on May 7, 2025?

The conference call is scheduled for 4:30 PM ET on May 7, 2025.

How can I access the Vanda Pharmaceuticals conference call?

Dial 1-800-715-9871 domestically or 1-646-307-1963 internationally with passcode 9941754.

What is the replay availability for the conference call?

The replay starts May 7, 2025, at 8:30 PM ET and ends May 14, 2025.

Where can I find Vanda Pharmaceuticals' conference call online?

The call will be archived on Vanda's website at www.vandapharma.com.

Last updated: May 2, 2025